« Return to News | Study Conduct

Icon launches new Icon Signature Series to share expertise in clinical development

Friday, March 22, 2013 03:04 PM

Icon, a global provider of outsourced development services, has launched the Icon Signature Series, a new thought leadership program that offers expert insight into value-driven strategies for clinical development. 

Built on over 20 years of helping biopharmaceutical companies accelerate the development of their drugs, Icon Signature Series brings together Icon and industry experts to share knowledge and expertise across all aspects of clinical development and post-approval strategies. Knowledge will be shared using a broad range of communication channels, including webinars, articles, whitepapers, symposia, workshops and videos. The program also offers an interactive discussion forum for biopharmaceutical companies to engage with Icon experts and their industry peers on the latest industry trends and developments. 

"Our global team comprises a powerhouse of deep insight in all fields related to clinical R&D,” said Dr. Mark Roseman, executive vice president of global scientific operations, Icon. “This, coupled with their practical experience in local markets makes them uniquely qualified to offer expert guidance on development practices, comment on emerging issues and help steer the industry's conversation on its future. The Icon Signature Series will be an invaluable resource to sponsor companies and is part of Icon’s on-going commitment to provide clients with strategic development solutions.”

The next Icon Signature Series webinar, titled "Enrichment Strategies for achieving greater clinical trial success," takes place on April 22.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.